Methyl 2-(4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) acetate

Ethyl (I+-R,I2S)-I2-(benzoylamino)-I+--hydroxybenzenepropanoate

pharmaceutical intermediate synthesis

2-(Chloromethyl)-3,5-dimethyl-4-nitropyridine

Pharmaceutical intermediate

Methyl 4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoate

Bexarotene impurity reference standard

O1-tert-butyl O3-ethyl 4-hydroxypiperidine-1,3-dicarboxylate

Pharmaceutical intermediate for piperidine derivatives

Methyl 2-((5-amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate

Research compound

Methyl 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate

n.a

RDEA 594

active pharmaceutical ingredient